In addition, multivariate analysis indicated MAST2 expression was an independent risk factor for RFS in liver cancer patients (HR = 1.517, 95%CI: 1.059–2.172, p = 0.023; Table 4). This evidence concerns the gene MAST2 and liver cancer.